Exhibit 32

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Allergy Research Group, Inc.
(the "Company") on Form 10-QSB for the period ending June 30, 2006 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I, Dr.
Stephen A. Levine, Chief Executive Officer and Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to ss.906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

              (1) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

              (2) The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.

Dated:  August 10, 2006

                                                By:  /s/ Stephen A. Levine
                                                     ----------------------
                                                Dr. Stephen A. Levine
                                                Chief Executive Officer and
                                                Chief Financial Officer

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Allergy Research Group, Inc. and
will be retained by Allergy Research Group, Inc. and furnished to the Securities
and Exchange Commission or its staff upon request.